Search Results - "Rizzo, Elisa"

Shaking table tests of a full‐scale flat‐bottom manufactured steel silo filled with wheat: Main results on the fixed‐base configuration by Silvestri, Stefano, Mansour, Sulyman, Marra, Matteo, Distl, Johann, Furinghetti, Marco, Lanese, Igor, Hernández‐Montes, Enrique, Neri, Caterina, Palermo, Michele, Pavese, Alberto, Rizzo Parisi, Elisa, Sadowski, Adam Jan, Selva, Francesco, Taniguchi, Tomoyo, Vadrucci, Laura, Weber, Felix

“…This paper reports on a series of shaking table tests on a full‐scale flat‐bottom steel silo filled with soft wheat, characterized by aspect ratio of around…”
Get full text

Defining dose-limiting toxicity for phase 1 trials of molecularly targeted agents: Results of a DLT-TARGETT international survey by Paoletti, Xavier, Le Tourneau, Christophe, Verweij, Jaap, Siu, Lillian L, Seymour, Lesley, Postel-Vinay, Sophie, Collette, Laurence, Rizzo, Elisa, Ivy, Percy, Olmos, David, Massard, Christophe, Lacombe, Denis, Kaye, Stan B, Soria, Jean-Charles

“…Abstract Introduction It is increasingly clear that definitions of dose-limiting toxicity (DLT) established for phase 1 trials of cytotoxic agents are not…”
Get full text

Palliative Treatment for Elderly Patients with Colon Cancer in Ten Italian Medical Oncology Units by PASETTO, Lara Maria, FALCI, Cristina, ONIGA, Francesco, BIASON, Rita, CONCETTA CHETRI, Maria, FEDELE, Palma, MASSARA, Giovanna, ROMANIELLO, Incoronata, GIORDANO, Monica, LUCHENA, Giovanna, BUZZI, Franco, RICOTTA, Riccardo, RIZZO, Elisa, SIENA, Salvatore, MONFARDINI, Silvio, DE SALVO, Gian Luca, GASPARINI, Giampietro, D'ANDREA, Mario, BAJETTA, Emilio, PLATANIA, Marco, ALABISO, Oscar, MIRAGLIA, Stefania

“…Background: Palliative chemotherapy significantly reduces mortality in patients with stage IV colon cancer, but is less prescribed with rising age. In this…”
Get full text

Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity by Vlenterie, Myrella, Litière, Saskia, Rizzo, Elisa, Marréaud, Sandrine, Judson, Ian, Gelderblom, Hans, Le Cesne, Axel, Wardelmann, Eva, Messiou, Christina, Gronchi, Alessandro, van der Graaf, Winette TA

“…Abstract Introduction Previous studies in metastatic soft tissue sarcomas (STS) showed that synovial sarcomas tend to have better survival rates and a higher…”
Get full text

Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents – Dose-Limiting Toxicity and Toxicity Assessment Recommendation Group for Early Trials of Targeted therapies, an European Organisation for Research and Treatment of Cancer-led study by Postel-Vinay, Sophie, Collette, Laurence, Paoletti, Xavier, Rizzo, Elisa, Massard, Christophe, Olmos, David, Fowst, Camilla, Levy, Bernard, Mancini, Pierre, Lacombe, Denis, Ivy, Percy, Seymour, Lesley, Le Tourneau, Christophe, Siu, Lillian L, Kaye, Stan B, Verweij, Jaap, Soria, Jean-Charles

“…Abstract Introduction Traditional dose-limiting toxicity (DLT) definition, which uses grade (G) 3–4 toxicity data from cycle 1 (C1) only, may not be…”
Get full text

Dose finding with longitudinal data: simpler models, richer outcomes by Paoletti, Xavier, Doussau, Adélaïde, Ezzalfani, Monia, Rizzo, Elisa, Thiébaut, Rodolphe

“…Phase I oncology clinical trials are designed to identify the optimal dose that will be recommended for phase II trials. This dose is typically defined as the…”
Get full text

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study by Pilotto, Sara, Rossi, Antonio, Vavalà, Tiziana, Follador, Alessandro, Tiseo, Marcello, Galetta, Domenico, Morabito, Alessandro, Di Maio, Massimo, Martelli, Olga, Caffo, Orazio, Piovano, Pier Luigi, Cortinovis, Diego, Zilembo, Nicoletta, Casartelli, Clelia, Banna, Giuseppe Luigi, Ardizzoia, Antonio, Barzelloni, Maria Luisa, Bearz, Alessandra, Genestreti, Giovenzio, Mucciarini, Claudia, Filipazzi, Virginio, Menis, Jessica, Rizzo, Elisa, Barbieri, Fausto, Rijavec, Erika, Cecere, Fabiana, Spitaleri, Gianluca, Bria, Emilio, Novello, Silvia

“…Micro-Abstract Non-small-cell lung cancer harboring uncommon epidermal growth factor receptor ( EGFR ) mutations (any mutation other than deletion 19 or…”
Get full text

GLI SCAVI E LE RICERCHE DEL DIPARTIMENTO DI CIVILTÀ ANTICHE E MODERNE DELL’UNIVERSITÀ DI MESSINA SUL COLLE DEL PALECASTRO DI TORTORA (L’ANTICA BLANDA): UN BILANCIO PRELIMINARE (2016-2019) by Fabrizio Mollo, Valentina Casella, Antonella Laino, Stefano Paderni, Elisa Rizzo, Maria Sergi, Patrizia Siclari, Marco Sfateria

“…Il colle Palecastro di Tortora (CS) si affaccia sul Golfo di Policastro ed è caratterizzato da un plateau sommitale che si sviluppa per ca. 5 ha ad una quota…”
Get full text

Predictors for doxorubicin-induced hematological toxicity and its association with outcome in advanced soft tissue sarcoma patients; a retrospective analysis of the EORTC-soft tissue and bone sarcoma group database by Sleijfer, Stefan, Rizzo, Elisa, Litière, Saskia, Mathijssen, Ron H J, Judson, Ian Robert, Gelderblom, Hans, Van Der Graaf, Winette T A, Gronchi, Alessandro

“…As both anti-tumour effects and toxicity are thought to be dose-dependent, patients with the greatest toxicity may also have the best outcome. We assessed…”
Get more information

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study by Vavalà, Tiziana, Follador, Alessandro, Tiseo, Marcello, Galetta, Domenico, Morabito, Alessandro, Di Maio, Massimo, Martelli, Olga, Caffo, Orazio, Piovano, Pier Luigi, Cortinovis, Diego, Zilembo, Nicoletta, Casartelli, Clelia, Banna, Giuseppe Luigi, Ardizzoia, Antonio, Barzelloni, Maria Luisa, Bearz, Alessandra, Genestreti, Giovenzio, Mucciarini, Claudia, Filipazzi, Virginio, Menis, Jessica, Rizzo, Elisa, Barbieri, Fausto, Rijavec, Erika, Cecere, Fabiana, Bria, Emilio, Spitaleri, Gianluca, Rossi, Antonio, Novello, Silvia

“…Non-small-cell-lung-cancer (NSCLC) patients harbouring epidermal growth factor receptor (EGFR) mutations develop drug resistance after 9-12 months of EGFR…”
Get full text

Association of hematological toxicity (tox) and outcome to doxorubicin (DOX) in advanced soft tissue sarcoma (STS): A retrospective analysis of the EORTC-Soft Tissue and Bone Sarcoma Group database by Sleijfer, Stefan, Rizzo, Elisa, Litière, Saskia, Mathijssen, Ron H.J., Judson, Ian Robert, Gelderblom, Hans, Italiano, Antoine, Van Der Graaf, Winette T.A., Gronchi, Alessandro

“…Abstract only…”
Get full text

Factors Predictive of Nonsentinel Lymph Node Involvement and Clinical Outcome in Melanoma Patients With Metastatic Sentinel Lymph Node by Rossi, Carlo Riccardo, De Salvo, Gian Luca, Bonandini, Elena, Mocellin, Simone, Foletto, Mirto, Pasquali, Sandro, Pilati, Pierluigi, Lise, Mario, Nitti, Donato, Rizzo, Elisa, Montesco, Maria Cristina

“…Background Identification of melanoma patients who need completion lymphadenectomy and adjuvant treatment after positive sentinel lymph node (SLN) biopsy would…”
Get full text

La modellazione 3D applicata ai beni culturali: la Pieve di San Giovanni Battista a Cavriglia by Elisa Rizzo

“…Sperimentazione ed applicazione integrata di due metodologie di rilievo, il laser scanning terrestre ed i sistemi fotogrammetrici Image-based, al fine di…”
Get full text

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients by Vavalà, Tiziana, Follador, Alessandro, Tiseo, Marcello, Galetta, Domenico, Morabito, Alessandro, Di Maio, Massimo, Martelli, Olga, Caffo, Orazio, Piovano, Pier Luigi, Cortinovis, Diego, Zilembo, Nicoletta, Casartelli, Clelia, Banna, Giuseppe Luigi, Ardizzoia, Antonio, Barzelloni, Maria Luisa, Bearz, Alessandra, Genestreti, Giovenzio, Mucciarini, Claudia, Filipazzi, Virginio, Menis, Jessica, Rizzo, Elisa, Barbieri, Fausto, Rijavec, Erika, Cecere, Fabiana, Bria, Emilio, Spitaleri, Gianluca, Rossi, Antonio, Novello, Silvia

“…•EGFR-TKIs first line treatment evidences impressive objectives response rates.•After 9–12 months acquired resistance to EGFR-TKIs arises.•No optimal therapy…”
Get full text

BE-POSITIVE: B eyond progression after tyrosine kinase inhibitor in E GFR- Positive non small cell lung cancer patients by Vavalà, Tiziana, Follador, Alessandro, Tiseo, Marcello, Galetta, Domenico, Morabito, Alessandro, Maio, Massimo Di, Martelli, Olga, Caffo, Orazio, Piovano, Pier Luigi, Cortinovis, Diego, Zilembo, Nicoletta, Casartelli, Clelia, Banna, Giuseppe Luigi, Ardizzoia, Antonio, Barzelloni, Maria Luisa, Bearz, Alessandra, Genestreti, Giovenzio, Mucciarini, Claudia, Filipazzi, Virginio, Menis, Jessica, Rizzo, Elisa, Barbieri, Fausto, Rijavec, Erika, Cecere, Fabiana, Bria, Emilio, Spitaleri, Gianluca, Rossi, Antonio, Novello, Silvia

“…Highlights • EGFR-TKIs first line treatment evidences impressive objectives response rates. • After 9–12 months acquired resistance to EGFR-TKIs arises. • No…”
Get full text

Factors Predictive of Nonsentinel Lymph Node Involvement and Clinical Outcome in Melanoma Patients With Metastatic Sentinel Lymph Node by Rossi, Carlo Riccardo, Luca De Salvo, Gian, Bonandini, Elena, Mocellin, Simone, Foletto, Mirto, Pasquali, Sandro, Pilati, Pierluigi, Lise, Mario, Nitti, Donato, Rizzo, Elisa, Cristina Montesco, Maria

Get full text

86 GENERALIZED YERSINIA ENIEROCOLITICA(YE) INFBCTION IN THALASSEMIC CHILDREN by Chiesa, Claudio, Pacifico, Lucia, Cianfrano, Vincenzo, Principe, Domenico Del, Rizzo, Elisa, Nanni, Frlvio, Midulla, Mario

Get full text